Keywords: corange, extends, stake, genemedicine, parent, boehringer, mannheim

Corange Extends Stake In GeneMedicine

Article | 12 February 1996

Corange, parent of Boehringer Mannheim, has extended its investment in GeneMedicine by purchasing 418,629 additional shares at $9.56 per share, bringing its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in